Table 1. Baseline characteristics and details of the catheter interventions.
| Patient | 1 | 2 | 3 | 4 | 5 | 6 | |
| Age, years | 47 | 38 | 61 | 34 | 35 | 60 | |
| Sex | M | F | F | M | F | M | |
| BMI | 26 | 26 | 34 | 29 | 22 | 25 | |
| Logistic EuroSCORE | 2.8 | 1.9 | 9.7 | 2.8 | 1.9 | 12.4 | |
| NT-proBNP, pg/ml | 736 | 695 | 6,520 | 320 | 112 | 2,680 | |
| Previous ICD implantation | 1 | 0 | 1 | 0 | 0 | 0 | |
| Medication | Beta-blocker | 1 | 1 | 1 | 1 | 0 | 1 |
| ACE/angiotensin receptor inhibitors | 1 | 1 | 1 | 1 | 0 | 1 | |
| Loop diuretics | 0 | 1 | 1 | 0 | 0 | 0 | |
| Mineralocorticoid antagonists | 1 | 0 | 1 | 1 | 0 | 1 | |
| Number of MitraClips | 1 | 1 | 2 | 2 | 2 | 2 | |
| Location of MitraClips | Anterior-posterior | 0 | 0 | 0 | 1 | 0 | 1 |
| Anterior-septal | 0 | 0 | 2 | 1 | 1 | 1 | |
| Posterior-septal | 1 | 1 | 0 | 0 | 1 | 0 | |
| Procedure time, min | 386 | 294 | 330 | 480 | 397 | 278 | |
| Fluoroscopy time, min | 41 | 44 | 32 | N/A | 18 | 38 | |
| Radiation dose, mGy | 1,105 | 847 | 1,560 | N/A | 360 | 1,293 | |
| Post-procedural TR severity | 3 | 1-2 | 2 | 2 | 1-2 | 1-2 | |
| Duration of ICU stay, days | 1 | 1 | 4 | 1 | 1 | 1 | |
| Duration of hospital stay, days | 3 | 4 | 10 | 10 | 7 | 4 | |
| ACE: angiotensin-converting enzyme; BMI: body mass index; ICD: implantable cardioverter-defibrillator; ICU: intensive care unit; N/A: not available; NYHA: New York Heart Association; TR: tricuspid regurgitation | |||||||